Drug profile · INN
copper histidinate
ZYCUBO
copper histidinate (ZYCUBO) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Drug details — copper histidinate
- US status
- approved
- Class
- —
- Route
- SUBCUTANEOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
copper histidinate (ZYCUBO) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is copper histidinate?
copper histidinate (ZYCUBO) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for copper histidinate?
ZYCUBO is a marketed brand name for copper histidinate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of copper histidinate?
copper histidinate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.